Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Incyte Corporation

http://www.incyte.com

Latest From Incyte Corporation

GSK’s Ojjaara Scores Myelofibrosis Nod After Round-The-World Journey

The US FDA approved the JAK inhibitor momelotinib for myelofibrosis with anemia, with an analyst forecasting peak sales of more than $425m.

Approvals Cancer

Deal Watch: Moderna, Immactics Team Up To Combine mRNA Technology With Cancer Cell Therapy

Plus deals involving Kelun Biotech, Pierre Fabre/Vertical, Novo Nordisk/Broad Institute, ABL Bio/Synaffix, Kriya/Tramontane, Palisade/Giiant and more.

Deal Watch Business Strategies

‘Small Biotech Exception’ From Medicare Price Negotiation Granted To Four Drugs For 2026

CMS has not disclosed how many requests for the exception it received but will follow up with applicants regarding its decisions this month.

Reimbursement Medicare

After All The Layoffs, Is Biopharma’s Headcount Still Growing?

While biotech layoffs and big pharma restructuring dominate the news in 2023, the sector’s job market remains buoyant.

Commercial Strategies Business Strategies
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Biotechnology
    • Drug Discovery Tools
      • ADMET
  • Other Names / Subsidiaries
    • Maxia Pharmaceuticals, Inc.
UsernamePublicRestriction

Register